Why the study?
Is QT prolongation more prevalent in Type 1 diabetic patients, particularly those with autonomic neuropathy, compared to non-diabetic controls?
Population
497 subjects, comprising 379 Type 1 diabetic patients with and without autonomic neuropathy, and 118…
Design
Cross-sectional
Authors
Loading...
QT prolongation may signal higher arrhythmia risk in type 1 diabetes with neuropathy; hypothesis-generating and requires prospective validation before screening changes.
Is QT prolongation more prevalent in Type 1 diabetic patients, particularly those with autonomic neuropathy, compared to non-diabetic controls?
QT prolongation is highly prevalent in Type 1 diabetic patients, particularly those with autonomic neuropathy, suggesting an increased risk for ventricular arrhythmias.
Sivieri et al. (1993) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: